Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kai Wang, Jinqiu Rao, Tingting Zhang, Qing Gao, Jichao Zhang, Chenxi Guang, Liqin Ding & Feng Qiu. (2020) Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity. Drug Design, Development and Therapy 14, pages 4423-4438.
Read now
Read now
Cynthia Ju & Timothy Reilly. (2012) Role of immune reactions in drug-induced liver injury (DILI). Drug Metabolism Reviews 44:1, pages 107-115.
Read now
Read now
Raúl J Andrade, Mercedes Robles & María Isabel Lucena. (2009) Rechallenge in drug-induced liver injury: the attractive hazard. Expert Opinion on Drug Safety 8:6, pages 709-714.
Read now
Read now
N. Somchit, C. W. Wong, A. Zuraini, A. Ahmad Bustamam, A. H. Hasiah, H. M. Khairi, M. R. Sulaiman & D. A. Israf. (2006) Involvement of Phenobarbital and SKF 525A in the Hepatotoxicity of Antifungal Drugs Itraconazole and Fluconazole in Rats. Drug and Chemical Toxicology 29:3, pages 237-253.
Read now
Read now
Amit S Kalgutkar & John R Soglia. (2005) Minimising the potential for metabolic activation in drug discovery. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 91-142.
Read now
Read now
Articles from other publishers (71)
Francesca Casini, Francesca Scaltrito, Maria Teresa Grimaldi, Tudor Lucian Pop, Valeria Calcaterra, Gian Vincenzo Zuccotti, Massimo Pettoello-Mantovani, Pietro Ferrara, Giovanni Corsello & Valentina Fabiano. (2023) Use of complementary and alternative medicine in children affected by oncologic, neurologic and liver diseases: a narrative review. Italian Journal of Pediatrics 49:1.
Crossref
Crossref
Cheru Parambath Sanoopa, Nikhil John & Kumari Chidambaran Chitra. (2022) Sublethal hepatotoxic effects and biotransformation response in the freshwater fish, Oreochromis mossambicus exposed to silicon dioxide nanoparticles. Biologia 77:9, pages 2507-2518.
Crossref
Crossref
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk & Monika A. Jakubowska. (2022) When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 600:11, pages 2579-2612.
Crossref
Crossref
Chand Basha Davuljigari, Frederick Adams Ekuban, Cai Zong, Alzahraa A. M. Fergany, Kota Morikawa & Gaku Ichihara. (2021) Nrf2 Activation Attenuates Acrylamide-Induced Neuropathy in Mice. International Journal of Molecular Sciences 22:11, pages 5995.
Crossref
Crossref
Brendan Le Daré, Pierre-Jean Ferron & Thomas Gicquel. (2021) Il était une fois l’hépatotoxicité…. médecine/sciences 37:3, pages 235-241.
Crossref
Crossref
Eve M. Manthorpe, Ian V. Jerrett, Grant T. Rawlin & Lucy Woolford. (2020) Plant and Fungal Hepatotoxicities of Cattle in Australia, with a Focus on Minimally Understood Toxins. Toxins 12:11, pages 707.
Crossref
Crossref
Ni Lin, Xiaobing Zhou, Xingchao Geng, Christopher Drewell, Juliane Hübner, Zuogang Li, Yingli Zhang, Ming Xue, Uwe Marx & Bo Li. (2020) Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents. Scientific Reports 10:1.
Crossref
Crossref
Sakina Sakina & Irmi Syafa'ah. (2020) The Role of Bronchoscopy in Hemoptysis. Jurnal Respirasi 6:2, pages 55.
Crossref
Crossref
Eva S.R. Gomes, Maria L. Marques & Frederico S. Regateiro. (2019) Epidemiology and Risk Factors for Severe Delayed Drug Hypersensitivity Reactions. Current Pharmaceutical Design 25:36, pages 3799-3812.
Crossref
Crossref
Yue Ma, Peiyan He, Xiaohua Tian, Guanglei Liu, Xiaowei Zeng & Guoqing Pan. (2019) Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier. ACS Applied Materials & Interfaces 11:27, pages 23948-23956.
Crossref
Crossref
Mohammad K. Parvez & Vikas Rishi. (2019) Herb-Drug Interactions and Hepatotoxicity. Current Drug Metabolism 20:4, pages 275-282.
Crossref
Crossref
Lin Zhang, Ting Wang, Bao-Sheng Zhao, Jing-Xuan Zhang, Song Yang, Chun-Lan Fan & Pin Li. (2019) Effect of 2″-O-Rhamnosyl Icariside II, Baohuoside I and Baohuoside II in Herba Epimedii on Cytotoxicity Indices in HL-7702 and HepG2 Cells. Molecules 24:7, pages 1263.
Crossref
Crossref
Burcu Guldiken, Gulay Ozkan, Gizem Catalkaya, Fatma Duygu Ceylan, Ipek Ekin Yalcinkaya & Esra Capanoglu. (2018) Phytochemicals of herbs and spices: Health versus toxicological effects. Food and Chemical Toxicology 119, pages 37-49.
Crossref
Crossref
Laura Palomo, Justyna Emilia Mleczko, Mikel Azkargorta, Javier Conde‐Vancells, Esperanza González, Felix Elortza, Félix Royo & Juan M. Falcon‐Perez. (2018) Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug‐Induced Liver Injury. Hepatology Communications 2:9, pages 1064-1079.
Crossref
Crossref
Alejandra Cano Paniagua & Pedro Amariles. 2018. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors.
N. Motamedi, N. Kaplowitz & L. Dara. 2018. Comprehensive Toxicology. Comprehensive Toxicology
608
624
.
C Ju, E Phillips, M.P. Holt, Y.R. Gao & C. Lammert. 2018. Comprehensive Toxicology. Comprehensive Toxicology
346
367
.
Nabil Noureddin & Neil Kaplowitz. 2018. Drug-Induced Liver Toxicity. Drug-Induced Liver Toxicity
3
18
.
O.N. Kramer & J. Albrecht. (2017) Clinical presentation of terbinafine‐induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic. British Journal of Dermatology 177:5, pages 1279-1284.
Crossref
Crossref
Daisuke Satoh, Satoru Iwado, Satoshi Abe, Kanako Kazuki, Shinobu Wakuri, Mitsuo Oshimura & Yasuhiro Kazuki. (2017) Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies. PLOS ONE 12:10, pages e0187072.
Crossref
Crossref
Amy Christine Brown. (2017) Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food and Chemical Toxicology 107, pages 472-501.
Crossref
Crossref
Bulent Cetin, Irem Bilgetekin, Mustafa Cengiz & Ahmet Ozet. (2017) Hepatotoxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: clinical practice and evidence. Drugs & Therapy Perspectives 33:8, pages 395-402.
Crossref
Crossref
Jiekun Xuan, Si Chen, Baitang Ning, William H. Tolleson & Lei Guo. (2016) Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. Chemico-Biological Interactions 255, pages 63-73.
Crossref
Crossref
Agnieszka Pedrycz & Agnieszka Kramkowska. (2016) Adriamycin - efficacy and possible adverse effects. Current Problems of Psychiatry 17:1.
Crossref
Crossref
T. I. Halenova, I. M. Vareniuk, N. M. Roslova, M. E. Dzerzhynsky, O. M. Savchuk, L. I. Ostapchenko, Yu. I. Prylutskyy, U. Ritter & P. Scharff. (2016)
Hepatoprotective effect of orally applied water-soluble pristine C
60
fullerene against CCl
4
-induced acute liver injury in rats
. RSC Advances 6:102, pages 100046-100055.
Crossref
Crossref
Naomi Jessurun & Eugene van Puijenbroek. (2015) Relationship Between Structural Alerts in NSAIDs and Idiosyncratic Hepatotoxicity: An Analysis of Spontaneous Report Data from the WHO Database. Drug Safety 38:5, pages 511-515.
Crossref
Crossref
Shima Hatamkhani, Hossein Khalili, Iman Karimzadeh, Simin Dashti-Khavidaki, Alireza Abdollahi & Sirous Jafari. (2014) Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: A randomized, clinical trial. Journal of Gastroenterology and Hepatology 29:5, pages 997-1004.
Crossref
Crossref
Sabrina Crepin, Bertrand Godet, Paul CarrierClaire Villeneuve, Louis Merle & Marie-Laure Laroche. (2014) Probable drug-induced liver injury associated with aliskiren: Case report and review of adverse event reports from pharmacovigilance databases. American Journal of Health-System Pharmacy 71:8, pages 643-647.
Crossref
Crossref
Annette M. Lopez & Robert G. Hendrickson. (2014) Toxin-Induced Hepatic Injury. Emergency Medicine Clinics of North America 32:1, pages 103-125.
Crossref
Crossref
Camilla Stephens, Maria Lucena & Raúl Andrade. 2014. Handbook of Personalized Medicine. Handbook of Personalized Medicine
1293
1333
.
Sandipan Datta, Fakhri Mahdi, Zulfiqar Ali, Mika B. Jekabsons, Ikhlas A. Khan, Dale G. Nagle & Yu-Dong Zhou. (2013) Toxins in Botanical Dietary Supplements: Blue Cohosh Components Disrupt Cellular Respiration and Mitochondrial Membrane Potential. Journal of Natural Products 77:1, pages 111-117.
Crossref
Crossref
Ahmed M. S. Hegazy & Usama A. Fouad. (2014) Evaluation of Lead Hepatotoxicity; Histological, Histochemical and Ultrastructural Study. Forensic Medicine and Anatomy Research 02:03, pages 70-79.
Crossref
Crossref
Ghazaleh Karimi, Kristina Star, G. Niklas Nor?n & Staffan H?gg. (2013) The Impact of Duration of Treatment on Reported Time-to-Onset in Spontaneous Reporting Systems for Pharmacovigilance. PLoS ONE 8:7, pages e68938.
Crossref
Crossref
M. Sistanizad & G. M. Peterson. (2013) Drug-induced liver injury in the Australian setting. Journal of Clinical Pharmacy and Therapeutics 38:2, pages 115-120.
Crossref
Crossref
Adrian Reuben. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
569
591
.
Rolf Teschke & Johannes Schulze. (2012) Suspected Herbal Hepatotoxicity. Drug Safety 35:12, pages 1091-1097.
Crossref
Crossref
Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze & Axel Eickhoff. (2012) Herbal hepatotoxicity: a tabular compilation of reported cases. Liver International 32:10, pages 1543-1556.
Crossref
Crossref
Mackenzie Hadi, Yixi Chen, Viktoriia Starokozhko, Marjolijn T. Merema & Geny M.M. Groothuis. (2012) Mouse Precision-Cut Liver Slices as an ex Vivo Model To Study Idiosyncratic Drug-Induced Liver Injury. Chemical Research in Toxicology 25:9, pages 1938-1947.
Crossref
Crossref
Rolf Teschke, Christian Frenzel, Johannes Schulze & Axel Eickhoff. (2012) Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained?. Regulatory Toxicology and Pharmacology 63:1, pages 1-9.
Crossref
Crossref
Xinsheng Gu & Jose E. Manautou. (2012) Molecular mechanisms underlying chemical liver injury. Expert Reviews in Molecular Medicine 14.
Crossref
Crossref
Alexander V. LyubimovWei Zou, Robert A. Roth & Patricia E. Ganey. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
25
.
Jae-Woo KwonEun-Soon ShinJong-Eun LeeSang-Heon KimSang-Hoon KimYoung-Koo JeeYoon-Keun KimHae-Sim Park, Kyung-Up MinHeung-Woo Park. (2012)
Genetic Variations in
TXNRD1
as Potential Predictors of Drug-Induced Liver Injury
. Allergy, Asthma & Immunology Research 4:3, pages 132.
Crossref
Crossref
Rolf Teschke, Xaver Glass & Johannes Schulze. (2011) Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports. Regulatory Toxicology and Pharmacology 61:3, pages 282-291.
Crossref
Crossref
Rolf Teschke & Albrecht Wolff. (2011) Regulatory causality evaluation methods applied in kava hepatotoxicity: Are they appropriate?. Regulatory Toxicology and Pharmacology 59:1, pages 1-7.
Crossref
Crossref
Hiroko Hosomi, Sho Akai, Keiichi Minami, Yukitaka Yoshikawa, Tatsuki Fukami, Miki Nakajima & Tsuyoshi Yokoi. (2010) An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and γ-glutamylcysteine synthetase knockdown cells. Toxicology in Vitro 24:3, pages 1032-1038.
Crossref
Crossref
S. Jain & N. Kaplowitz. 2010. Comprehensive Toxicology. Comprehensive Toxicology
369
381
.
B. van Ravenzwaay, G. C. Cunha, E. Fabian, M. Herold, H. Kamp, G. Krennrich, A. Krotzky, E. Leibold, R. Looser, W. Mellert, A. Prokoudine, V. Strauss, R. Trethewey, T. Walk & J. Wiemer. 2010. An Omics Perspective on Cancer Research. An Omics Perspective on Cancer Research
141
166
.
Michael Holt & Cynthia Ju. 2010. Adverse Drug Reactions. Adverse Drug Reactions
3
27
.
Raúl J Andrade, Mercedes Robles, Eugenia Ulzurrun & M Isabel Lucena. (2009) Drug-induced liver injury: insights from genetic studies. Pharmacogenomics 10:9, pages 1467-1487.
Crossref
Crossref
Giovanni Tarantino, Matteo Nicola Dario Di Minno & Domenico Capone. (2009) Drug-induced liver injury: Is it somehow foreseeable?. World Journal of Gastroenterology 15:23, pages 2817.
Crossref
Crossref
Hajime Takikawa. (2009) Recent status of drug-induced liver injury. Hepatology Research 39:1, pages 1-6.
Crossref
Crossref
Rolf Teschke, Alexander Schwarzenboeck & Karl-Heinz Hennermann. (2008) Causality assessment in hepatotoxicity by drugs and dietary supplements. British Journal of Clinical Pharmacology 66:6, pages 758-766.
Crossref
Crossref
Rolf Teschke, Alexander Schwarzenboeck & Karl-Heinz Hennermann. (2008) Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. European Journal of Gastroenterology & Hepatology 20:12, pages 1182-1193.
Crossref
Crossref
T. J. Miller, A. Knapton, O. Adeyemo, L. Noory, J. Weaver & J. P. Hanig. (2008) Cytochrome c: a non‐invasive biomarker of drug‐induced liver injury. Journal of Applied Toxicology 28:7, pages 815-828.
Crossref
Crossref
Louis Ignarro, David Heber, Y. Steven Henig & Ezra Bejar. (2008) Herbalife nutritional products and liver injury revisited. Journal of Hepatology 49:2, pages 291-293.
Crossref
Crossref
Laura E. Randle, Chris E.P. Goldring, Craig A. Benson, Peter N. Metcalfe, Neil R. Kitteringham, B. Kevin Park & Dominic P. Williams. (2008) Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice. Toxicology 243:3, pages 249-260.
Crossref
Crossref
Amit S. Kalgutkar. 2008. Advances in Bioactivation Research. Advances in Bioactivation Research
1
29
.
Wissam Bleibel, Stephen Kim, Karl D’Silva & Eric R. Lemmer. (2007) Drug-Induced Liver Injury: Review Article. Digestive Diseases and Sciences 52:10, pages 2463-2471.
Crossref
Crossref
Basuki K. Gunawan & Neil Kaplowitz. (2007) Mechanisms of Drug-Induced Liver Disease. Clinics in Liver Disease 11:3, pages 459-475.
Crossref
Crossref
Kevin P DeSanty & Celene M Amabile. (2016) Antidepressant-lnduced Liver Injury. Annals of Pharmacotherapy 41:7-8, pages 1201-1211.
Crossref
Crossref
Basuki Gunawan & Neil Kaplowitz. 2007. Textbook of Hepatology. Textbook of Hepatology
1269
1276
.
Gebran Abboud & Neil Kaplowitz. (2007) Drug-Induced Liver Injury. Drug Safety 30:4, pages 277-294.
Crossref
Crossref
Abdul Mutlib, Ping Jiang, Jim Atherton, Leslie Obert, Seva Kostrubsky, Steven Madore & Sidney Nelson. (2006)
Identification of Potential Genomic Biomarkers of Hepatotoxicity Caused by Reactive Metabolites of
N
-Methylformamide: Application of Stable Isotope Labeled Compounds in Toxicogenomic Studies
. Chemical Research in Toxicology 19:10, pages 1270-1283.
Crossref
Crossref
Georgina Meneses-Lorente, Melanie Zea Sakatis, Timothy Schulz-Utermoehl, Claudio De Nardi & Alan P. Watt. (2006) A quantitative high-throughput trapping assay as a measurement of potential for bioactivation. Analytical Biochemistry 351:2, pages 266-272.
Crossref
Crossref
Michael P. Holt & Cynthia Ju. (2006) Mechanisms of drug-induced liver injury. The AAPS Journal 8:1, pages E48-E54.
Crossref
Crossref
Norberto A. Guzman, R. John Stubbs & Terry M. Phillips. (2006) Determination of inflammatory biomarkers by immunoaffinity capillary electrophoresis. Drug Discovery Today: Technologies 3:1, pages 29-37.
Crossref
Crossref
Clive P Page, Michael J Curtis, Michael J A Walker & Brian B Hoffman. 2006. Integrated Pharmacology. Integrated Pharmacology
51
64
.
. 2006. Molekulare Pharmakologie und Toxikologie. Molekulare Pharmakologie und Toxikologie
153
259
.
K. Trudel, D. Sinnett, R.W. James, E. Delvin, D. Amre, E. Seidman & E. Levy. (2005) Iron–ascorbic acid‐induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats. Journal of Cellular Biochemistry 96:2, pages 404-411.
Crossref
Crossref
Neil Kaplowitz. (2005) Idiosyncratic drug hepatotoxicity. Nature Reviews Drug Discovery 4:6, pages 489-499.
Crossref
Crossref
Robert G. Batey, Ses J. Salmond & Alan Bensoussan. (2005) Complementary and alternative medicine in the treatment of chronic liver disease. Current Gastroenterology Reports 7:1, pages 63-70.
Crossref
Crossref